Merchavia Holdings and Investments

Merchavia Holdings and Investments specializes in investing in Israeli life sciences and med-tech startups. Its current focus includes diagnostic technologies for cancer detection, wearable medical monitoring devices, digital therapeutics for chronic pain conditions like neuropathic pain and fibromyalgia ("TrainPain"), women's health products such as hormone-free intrauterine contraceptives ("Ballerine"), AI-driven neuromonitoring tools to prevent nerve injury during surgery, hand-held blood count diagnostics ("RevDx"), smart air quality management platforms ("Aura smart air"), cannabis inhaler devices with app integration for dosing control, among others. One women's health product targeting abnormal uterine bleeding has reached Phase IIa clinical trials. The company's strategy involves early-stage to mid-stage investments with some products already commercialized or near commercialization.